| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042489409 |
| P356 | DOI | 10.1038/SJ.KI.5001608 |
| P698 | PubMed publication ID | 16788689 |
| P2093 | author name string | Wong H | |
| Drukker A | |||
| Feber J | |||
| Filler G | |||
| Mylrea K | |||
| P2860 | cites work | The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 |
| Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children | Q24675784 | ||
| Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis | Q28216384 | ||
| National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification | Q35141279 | ||
| Chronic renal failure and growth | Q35624548 | ||
| Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey | Q44261213 | ||
| Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? | Q44550988 | ||
| Epidemiology of pediatric chronic kidney disease | Q44913988 | ||
| Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study. | Q50632317 | ||
| Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. | Q50986483 | ||
| The cognitive development of pre-school children treated for chronic renal failure | Q52206975 | ||
| Early diagnosis of juvenile renal osteodystrophy | Q71271141 | ||
| Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood | Q71499766 | ||
| The advantage of a uniform terminology and staging system for chronic kidney disease (CKD) | Q73745971 | ||
| Chronic renal failure in pediatrics 1996. Chilean survey | Q78150156 | ||
| Changing trends in the referral patterns of pediatric nephrology patients | Q81533942 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 585-590 | |
| P577 | publication date | 2006-06-21 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Prevalence of complications in children with chronic kidney disease according to KDOQI | |
| P478 | volume | 70 |
| Q55419676 | A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging. |
| Q37682240 | A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program |
| Q37042133 | Anemia and risk of hospitalization in pediatric chronic kidney disease |
| Q79635047 | Anemia in children with chronic kidney disease |
| Q37152477 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study |
| Q28386914 | Blood lead level and measured glomerular filtration rate in children with chronic kidney disease |
| Q36392732 | CKiD (CKD in children) prospective cohort study: a review of current findings. |
| Q87393483 | Chapter 6: Blood pressure management in children with CKD ND |
| Q47711649 | Children's, parents' and other stakeholders' perspectives on early dietary self-management to delay disease progression of chronic disease in children: a protocol for a mixed studies systematic review with a narrative synthesis |
| Q37455044 | Chronic kidney disease in children: A report from a tertiary care center over 11 years |
| Q38087529 | Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options |
| Q40019579 | Clinical characteristics and prevalence of complications of chronic kidney disease in children: the Taiwan Pediatric Renal Collaborative study |
| Q38988030 | Complications of pediatric live-donor kidney transplantation: a single center's experience in Egypt |
| Q50541249 | Developmental changes of MPA exposure in children. |
| Q40012831 | Effect of elevated blood pressure on quality of life in children with chronic kidney disease |
| Q37268819 | End-stage kidney disease after pediatric nonrenal solid organ transplantation |
| Q37195386 | Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q34588377 | Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study |
| Q36666815 | Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. |
| Q50512533 | High prevalence of elevated lead levels in pediatric dialysis patients. |
| Q36407313 | Hypertension in children with chronic kidney disease: pathophysiology and management |
| Q41200646 | Hypertension in pediatric patients with chronic kidney disease: management challenges |
| Q37895175 | Iron deficiency in children with early chronic kidney disease |
| Q42784003 | Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease |
| Q54320254 | Losartan and enalapril are comparable in reducing proteinuria in children. |
| Q38134288 | Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease |
| Q37589035 | Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice |
| Q35559034 | Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients |
| Q34109258 | Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis |
| Q38006631 | Pharmaceutical cost distribution in childhood chronic kidney disease. |
| Q26777613 | Pre-treatment considerations in childhood hypertension due to chronic kidney disease |
| Q42953475 | Preliminary findings of serum creatinine and estimated glomerular filtration rate (eGFR) in adolescents with intellectual disabilities |
| Q35278515 | Progression of pediatric CKD of nonglomerular origin in the CKiD cohort |
| Q38879216 | Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies |
| Q33683988 | Randomized, double-blind, controlled study of losartan in children with proteinuria. |
| Q93609101 | References |
| Q39012275 | Renal formulas pretreated with medications alters the nutrient profile |
| Q90377031 | Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay |
| Q36951249 | Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy |
| Q34169794 | Risk factors for progression of chronic kidney disease |
| Q36330458 | Role of 24-h ambulatory blood pressure monitoring in children with chronic kidney disease |
| Q36586848 | Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study |
| Q85637735 | Selection of infants who potentially have congenital anomalies of the kidney and urinary tract from a large cohort for a more thorough examination |
| Q35226354 | The impact of inflammation on bone mass in children |
| Q46669555 | Why multidisciplinary clinics should be the standard for treating chronic kidney disease |
Search more.